Medical Professional Publications

Pharmacy and Therapeutics Committee Updates

(From the November 2017 Issue of MedStat)

The following actions were taken at the 10/5/17 Pharmacy & Therapeutics Committee meeting:

  • Changes to the Amphotericin B Drug Administration Instructions were APPROVED.
  • Changes to the Transport Bag Contents were APPROVED.
  • Changes to the Eye Clinic stocklist were APPROVED.
  • Changes to the Rheumatology Dublin Clinic stocklist were APPROVED.
  • Changes to the ID/TB Clinic stocklist were APPROVED.
  • Lumason (Sulfur Hexafluoride Lipid-Type A Microspheres) was ADDED to formulary.
  • Topical Capsaicin was ADDED to formulary.
  • SMOF Lipid was ADDED to formulary.

The following actions were taken at the 9/7/17 Pharmacy & Therapeutics Committee meeting:

  • Magnesium IV Administration Guideline was APPROVED.
  • OpenBiome (fecal microbiota transplant) was NOT APPROVED for addition to formulary.
  • Zarxio (filgrastim-dyyb) was APPROVED for addition to formulary.
  • Tresiba (insulin degludec) was NOT APPROVED for addition to formulary.
  • Kyleena (levonorgestrel-releasing intra-uterine device) was APPROVED for addition to formulary.                                             

For more information, contact Michael Storey at Michael.Storey@NationwideChildrens.org.

myChildren’s mobile app

iPhone and Android.

Download Today! »

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000